|
Perillyl alcohol Clinical Trials
1 actively recruiting trial across 1 location
Also known as: NEO100
Los Angeles, California1 trial
Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma
University of Southern California
Phase 1/2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.